Pharma Marketing Network

MARCH 26, 2025

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. From generative AI tools that draft emails to predictive algorithms that segment target audiences, the speed and scale of innovation are staggering. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?

Compliance 64

Compliance Marketing Regulation Pharma Companies 64

Rethinking Clinical Trials

MARCH 27, 2025

Speaker Alexander J. AJ Blood, MD, MSc Associate Director, Accelerator for Clinical Transformation Research Group Instructor of Medicine at Harvard Medical School Cardiologist and Intensivist Brigham and Womens Hospital Slides Keywords Artificial Intelligence; Cost; Large Language Models; Enrollment; Eligibility; Recruitment Key Points The Accelerator for Clinical Transformation (ACT) is a research group that seeks to use emerging technology to try and expand access to

Clinical Trials 147

Clinical Trials Clinical Trials Trials Cardiology 147

Bio Pharma Dive

MARCH 27, 2025

The FDA will lose about 3,500 employees under the plans, although HHS said drug, medical device and food reviewers will not be affected.

Drugs 332

Drugs 332

Pharmaceutical Technology

MARCH 24, 2025

AstraZeneca has announced a $2.5bn investment to establish the companys sixth worldwide strategic R&D centre in China.

264

264

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

XTalks

MARCH 26, 2025

After a strong showing in 2024, leading packaged foods company BBB Foods saw their stocks rise from $17.50 to over $28 per share, followed by a successful secondary offering this year. Moreover, Guzman y Gomezs, a renowned Australian fast-casual chain known for a fresh, made-to-order Mexican food experience, whose shares surged 37% on debut, now has its very first location in Illinois.

Packaging 105

Packaging Packaging Protein Production 105

Rethinking Clinical Trials

MARCH 26, 2025

Dr. Matthew Engelhard and Anivarya Kumar In this Friday’s PCT Grand Rounds, Matthew Engelhard and Anivarya Kumar of Duke University will present “A Cross-Sectional Study of GPT-4Based Plain Language Translation of Clinical Notes to Improve Patient Comprehension of Disease Course and Management.” The Grand Rounds session will be held on Friday, March 28, 2025, at 1:00 pm eastern.

Bioinformatics 162

Bioinformatics Clinical Trials Clinical Trials Trials 162

Pharmaceutical Technology

MARCH 24, 2025

The FDA has granted approval for the IND application of Everest Medicines tumour-associated antigen (TAA) vaccine, EVM14.

FDA Approval 263

FDA Approval Vaccine Vaccination Medicine 263

Medical Xpress

MARCH 28, 2025

According to a recent study from the University of Jyvskyl, Finland, the impacts of everyday physical activity do not attenuate the accelerated hormonal bone loss that occurs during menopause. Effective bone-loading impacts are rare in everyday life. Future research should explore whether more targeted exercise can slow menopausal bone loss. The study suggests that impacts accumulated during everyday life are not sufficient to slow hormonal bone loss during menopause.

Hormones 86

Hormones Research Gerontology 86

XTalks

MARCH 26, 2025

Purple Day 2025, celebrated on March 26, has set sail with the theme Power In Purple, honoring the strength and resilience of individuals living with epilepsy. Organized in collaboration between the Epilepsy Foundation and The Anita Kaufmann Foundation, this years Purple Day highlights the importance of solidarity, visibility and education. Epilepsy is characterized by recurrent, unprovoked seizures caused by irregular brain activity.

Life Science 66

Life Science Gene Expression Trials Drugs 66

Bio Pharma Dive

MARCH 28, 2025

Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal the verdict, a strategy successfully employed by Eisai.

Regulation 290

Regulation Marketing 290

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

MARCH 27, 2025

GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.

Sales 246

Sales Drugs 246

Medical Xpress

MARCH 28, 2025

In what is believed to be a world-first study, researchers from the University of Adelaide's Australian Dysautonomia and Arrhythmia Research Collaborative (ADARC) have used brain scans to identify blood flow problems in people with postural orthostatic tachycardia syndrome (POTS).

Research 145

Research 145

FDA Law Blog

MARCH 25, 2025

By Adrienne R. Lenz, Principal Medical Device Regulation Expert Last year, FDA issued a letter to the medical device industry warning medical device firms of concerns related to fraudulent and unreliable laboratory testing data in premarket submissions, which we blogged about here. This was followed last September with warning letters issued to two Chinese firms performing biocompatibility testing, citing violations of 21 C.F.R.

Containment 59

Containment Regulation Manufacturing 59

Bio Pharma Dive

MARCH 26, 2025

The company plans to file next year for an accelerated clearance of its "exon-skipping" treatment, which would compete with one of Sarepta's medicines.

Medicine 273

Medicine Drugs 273

Advertisement

Clinical Supply

Pharmaceutical Technology

MARCH 26, 2025

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity data.

Vaccine 246

Vaccine Vaccination Trials 246

Velocity Clinical Research

MARCH 23, 2025

Clinical trials have been steadily leaving the UK for years. In 2021, just 2.2% of patients recruited to global trials were from the UK. By contrast, France, which has a similar population size, accounted for 3.9% that year. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

Pharma Times

MARCH 27, 2025

Janssen drug combination extends life expectancy during trial

Trials 125

Trials Drugs 125

Bio Pharma Dive

MARCH 26, 2025

The Johns Hopkins surgeon will helm the agency as layoffs loom and important decisions on treatments for rare and infectious diseases await.

259

259

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

MARCH 28, 2025

The Macau Special Administrative Region (ISAF) Pharmaceutical Administration Bureau has approved IASO Bio's NDA for equecabtagene autoleucel.

240

240

Drug Patent Watch

MARCH 26, 2025

The Unseen Hurdles of Generic Drug Development: Lessons Learned As the pharmaceutical industry continues to evolve, one thing remains constant: the pursuit of affordable, high-quality medications for patients worldwide. Generic drugs have long been a vital part of this equation, offering a more accessible alternative to brand-name medications. However, the journey to bringing a generic drug to market is often fraught with challenges.

Generic Drugs 52

Generic Drugs Compliance Development Drugs 52

Pharma Times

MARCH 26, 2025

NOUS-209 shows potential to intercept cancer in its early stages

122

122

Bio Pharma Dive

MARCH 28, 2025

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients who are eligible for treatment.

Drugs 253

Drugs 253

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharmaceutical Technology

MARCH 25, 2025

The study will analyse electronic health records of 65- and 66-year olds from the UKs National Health Service (NHS).

Research 227

Research 227

Drug Discovery World podcast

MARCH 26, 2025

This is the latest episode of the free DDW narrated podcast, titled Innovation enabled by new drug discovery technologies, which covers two articles written for DDW Volume 24 Issue 3, Summer 2023. They are called: CRISPR breakthroughs: New solutions for common diseases and Re-assessing the risks of drug-induced arrhythmias during drug discovery .

Drugs 52

Drugs DNA Genomics Genome 52

Medical Xpress

MARCH 28, 2025

As a measles outbreak spreads across the U.S., doctors are now seeing a new and unexpected danger: children getting sick from taking too much vitamin A.

Doctor 118

Doctor Doctors 118

Bio Pharma Dive

MARCH 24, 2025

Speed vs. success in oncology trials: Discover data-driven strategies to accelerate drug development.

Development 246

Development Drugs Trials 246

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Pharmaceutical Technology

MARCH 27, 2025

In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the pharmacological management of moderate-to-severe ulcerative colitis (UC) in gastroenterology.

219

219

XTalks

MARCH 26, 2025

In the fast-evolving field of clinical research, thought leaders do more than just keep up; they lead the charge and shape the direction of the industry. True thought leadership is achieved by consistently providing valuable insights, challenging the status quo and offering innovative solutions that address the fields most pressing challenges. Businesses that establish themselves as trusted voices not only gain credibility but also attract key partnerships and position themselves as pioneers.

Clinical Research 52

Clinical Research Research Branding Clinical Trials 52

Medical Xpress

MARCH 28, 2025

Many everyday skills, such as speech, are not innate. They are learned through trial and error. Now, by analyzing young songbirds rehearsing their fathers' songs, researchers at Columbia's Zuckerman Institute have for the first time witnessed the role that the brain's reward machinery plays as the brain naturally learns over time through practice.

Trials 116

Trials Research 116

Bio Pharma Dive

MARCH 24, 2025

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

Development 243

Development 243

Advertisement

Clinical Supply